Literature DB >> 8168036

p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.

Y S Lee1, M Teh.   

Abstract

BACKGROUND: Expression of p53 protein has been described in a variety of human malignant tumors. Recent reports have also demonstrated its presence in benign and reactive lesions. The significance of p53 expression is unclear.
METHODS: This study examines the p53 expression in proliferative lesions of skin, including 6 pseudoepitheliomatous hyperplasia, 33 keratoacanthoma, and 45 squamous cell carcinoma, and to evaluate its significance.
RESULTS: p53 expression was observed in all of the six cases of pseudoepitheliomatous hyperplasia, 78.8% of keratoacanthoma, and 75.5% of squamous cell carcinoma. The staining pattern of pseudoepitheliomatous hyperplasia and keratoacanthoma was generally less intense and extensive compared with that of squamous cell carcinoma. A keratoacanthoma with nuclear atypia that showed strong and extensive p53 staining was also encountered. The perilesional skin in sun-exposed sites often showed the presence of p53-positive keratinocytes. Control skin taken from the buttock was negative for p53 protein. Conversely, p53 was often expressed in carcinomas arising from sun-exposed as well as sun-protected sites. p53 positivity involved mainly the undifferentiated cells at the base of the epidermis or periphery of tumor cords. Differentiated keratinized cells were not stained. p53-positive fibroblasts were also noted in the inflammatory and granulation tissues of pseudoepitheliomatous hyperplasia.
CONCLUSIONS: p53 expression in skin is common and appears to be an early event in a series of genetic alterations reflecting underlying actinic damage, which may lead to but does not necessarily indicate neoplastic or malignant transformation. Because p53 staining is seen in proliferative and undifferentiated cells and ceases to be expressed when the cells differentiate, it appears that the expression of p53 protein, mutant or wild-type, is an indicator of immaturity and proliferative capacity of the cell rather than one of neoplasia or malignancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168036     DOI: 10.1002/1097-0142(19940501)73:9<2317::aid-cncr2820730913>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  p53 and MDM2 protein expression in actinic cheilitis.

Authors:  Maria da Conceição Andrade de Freitas; Luciana Maria Pedreira Ramalho; Flávia Caló Aquino Xavier; André Luis Gomes Moreira; Sílvia Regina Almeida Reis
Journal:  J Appl Oral Sci       Date:  2008 Nov-Dec       Impact factor: 2.698

Review 2.  Pseudoepitheliomatous Hyperplasia in Oral Lesions: A Review.

Authors:  Vaidhehi Narayan Nayak; K Uma; H C Girish; Sanjay Murgod; K Shyamala; Ranajit B Naik
Journal:  J Int Oral Health       Date:  2015-09

3.  Clinical, histopathological and immunohistochemical study of keratoacanthoma.

Authors:  Alina Maria Vîlcea; Loredana Elena Stoica; Claudia Valentina Georgescu; Florina Carmen Popescu; Raluca Niculina Ciurea; Ionică Daniel Vîlcea; Cecil Sorin Mirea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

4.  Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.

Authors:  Tack Kune You; Kyoung Min Kim; Sang Jae Noh; Jun Sang Bae; Kyu Yun Jang; Myoung Ja Chung; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Ho Sung Park
Journal:  Korean J Pathol       Date:  2012-08-23

5.  Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.

Authors:  A J Waring; M Takata; I Rehman; J L Rees
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

Review 6.  Pseudoepitheliomatous Hyperplasia: Relevance in Oral Pathology.

Authors:  R Sarangarajan; V K Vaishnavi Vedam; G Sivadas; R Krishnaraj; Anuradha Sarangarajan; K T Shanmugam
Journal:  J Int Oral Health       Date:  2015-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.